β-Nitrostyrenes as Potential Anti-leishmanial Agents

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Leishmaniasis treatment requires novel therapeutic strategies.
• β-nitrostyrenes represent a potential class of antileishmanial agents.

Purpose of the Study:

• To synthesize and evaluate the antileishmanial activity of novel β-nitrostyrenes against *Leishmania donovani*.
• To assess the efficacy against both *in vitro* promastigotes and intracellular amastigotes.
• To determine the safety profile of active compounds on mammalian macrophages.

Main Methods:

• Synthesis of β-nitrostyrenes via Henry reaction.
• Antimicrobial and antileishmanial activity assessed using broth microdilution and standard assays.
• In vitro activity evaluated against *L. donovani* promastigotes and intracellular amastigotes.
• Cytotoxicity assessed on mammalian macrophages.

Main Results:

• Compounds 9, 12, 14, and 18 demonstrated significant *in vitro* activity against *L. donovani* promastigotes and amastigotes.
• IC50 values for active compounds ranged from 23.40 to 55.66 nM against promastigotes and 21.46 to 61.63 nM against amastigotes.
• Active compounds showed no toxicity to mammalian macrophages at 25 μM and induced moderate nitric oxide levels.

Conclusions:

• Specific β-nitrostyrene derivatives exhibit potent *in vitro* leishmanicidal activity.
• These compounds represent promising candidates for further development as anti-leishmaniasis therapeutics.
• The non-toxic profile and mechanism involving nitric oxide induction warrant further investigation.